Posted in | News | Display

New DLP Pico Chipset for Ultra-Compact Mobile and Wearable Devices from TI

Today at IFA 2013, Texas Instruments (TI) DLP® Products unveiled its newest DLP Pico™ chipset, the 0.2” TRP, which brings unparalleled brightness through greater optical/power efficiency, and higher resolution to next-generation smartphones, tablets, digital cameras and wearable devices, such as near-eye displays.

The 0.2” TRP chipset, the latest in the DLP Pico family, is the first to incorporate the Tilt & Roll Pixel (TRP) architecture announced at CES 2013, as well as the adaptive IntelliBrightTM suite of algorithms demonstrated at Mobile World Congress earlier this year.

With the ability to produce up to 100 percent higher brightness on a frame-by-frame basis while consuming up to 50 percent less power, the new 0.2” TRP chipset also features twice the resolution of its predecessor. The result is bright, detailed images with a life-like quality, making DLP Pico the ultimate means of sharing life’s experiences, anytime and anywhere.

“We believe that through the creativity and passion of our customers, the 0.2” TRP chipset will set a completely new benchmark for big picture experiences from mobile devices,” said Frank Moizio, business unit manager of DLP Pico. “We expect their pioneering products to create the most compelling and unique displays, transforming the value of mobile experiences.”

Beyond traditional mobile electronics, DLP Pico is finding applications in emerging technologies like the growing wearables market. As with many wearable devices, the design of near-eye displays presents a unique design challenge, requiring a critical balance of both style and performance. In this arena, DLP Pico excels, as described by Paul Travers, CEO of Vuzix:

“Given the aggressive power and brightness needs of our see-through near-eye display products, the new DLP Pico chipset is a perfect fit,” said Travers. “The combination of unmatched power savings and high contrast lets us deliver consumers longer battery life while creating a brighter, more vibrant image than we would be able to achieve with any other technology.”

World class brands and manufacturers are actively designing products with the new DLP Pico chip. If you too are interested in adding DLP Pico technology to your product, please visit http://www.dlp.com/2trp-pico-chip-press/en to obtain a development evaluation module. To learn more about DLP Pico during IFA 2013, please email [email protected] to set up a meeting with a DLP representative.

You can follow DLP on Twitter at @TI_DLP and on YouTube at YouTube.com/DLPTechnology. For the latest on other applications for DLP technology overall, please visit DLP.com.

Source: http://www.dlp.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    DLP Texas Instruments. (2019, February 26). New DLP Pico Chipset for Ultra-Compact Mobile and Wearable Devices from TI. AZoOptics. Retrieved on April 25, 2024 from https://www.azooptics.com/News.aspx?newsID=17842.

  • MLA

    DLP Texas Instruments. "New DLP Pico Chipset for Ultra-Compact Mobile and Wearable Devices from TI". AZoOptics. 25 April 2024. <https://www.azooptics.com/News.aspx?newsID=17842>.

  • Chicago

    DLP Texas Instruments. "New DLP Pico Chipset for Ultra-Compact Mobile and Wearable Devices from TI". AZoOptics. https://www.azooptics.com/News.aspx?newsID=17842. (accessed April 25, 2024).

  • Harvard

    DLP Texas Instruments. 2019. New DLP Pico Chipset for Ultra-Compact Mobile and Wearable Devices from TI. AZoOptics, viewed 25 April 2024, https://www.azooptics.com/News.aspx?newsID=17842.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.